Arlington, TX, United States of America

Bryon Severns

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2004-2012

Loading Chart...
4 patents (USPTO):

Title: Innovator Bryon Severns: Advancing Ophthalmic Treatments from Arlington, TX

Introduction

Bryon Severns, an accomplished inventor based in Arlington, TX, has made significant contributions to the field of ophthalmology through his innovative inventions. With a remarkable portfolio of four patents, he has focused on developing new treatments for ocular hypertension and glaucoma, two prevalent eye conditions that can lead to vision loss.

Latest Patents

Among Severns' latest inventions are two notable patents aimed at managing intraocular pressure and treating related diseases. The first patent centers on "Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma." This invention introduces compositions and methods that utilize bradykinin agonists to treat and prevent ocular disorders associated with increased intraocular pressure. The second patent, "6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions," details methods employing these analogs to address rho kinase-mediated conditions, including controlling intraocular pressure and providing treatments for glaucoma. Furthermore, it discloses ophthalmic pharmaceutical compositions that contain effective amounts of 6-aminoimidazo[1,2-b]pyridazine analogs for enhancing eye health.

Career Highlights

Bryon Severns has honed his expertise while working in the prominent eye care companies of Alcon, Inc. and Alcon Research, Ltd. His career is marked by his dedication to improving patient outcomes in the realm of eye diseases. Through his work, he has consistently focused on innovative therapeutic solutions that bridge the gap between scientific research and clinical application.

Collaborations

Throughout his professional journey, Severns has collaborated with fellow researchers and inventors, including Hwang-Hsing Chen and Jesse Albert May. These partnerships have likely contributed to his success in developing groundbreaking treatments that address critical needs in ophthalmology.

Conclusion

With a growing number of patents and a career dedicated to advancing ocular health, Bryon Severns stands out as a key figure in the field of ophthalmic innovation. His work not only highlights the importance of research and development in treating eye diseases but also underscores the impact that committed inventors can have on improving the quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…